Iris BioTechnologies Welcomes New Board Member and Key Employees
Marketwired - Tue Jan 27, 7:23PM CST
Iris BioTechnologies Inc. (OTCQB: IRSB), a life sciences company poised to set new personalized medicine standards for precision diagnosis and therapy, is pleased to welcome Dr. Douglas Hendren, Dr. John Hearst, Dr. Frank Chuang, and Gayle Murray to our team at a very exciting time in the growth of our company. In the State of the Union speech on January 20, 2015, President Obama said, "Personalized medicine represents a revolutionary and exciting change in the fundamental approach and practice of medicine."
Iris BioTechnologies CEO Simon Chin Will Discuss Big Data at the World's Largest Gathering for Laboratory Medicine at AACC 2014
Marketwire - Wed Jul 09, 8:18AM CDT
Iris BioTechnologies Inc. (OTCQB: IRSB) is a life sciences company and is a leader in the Invitro Diagnostic (IVD) industry.
Iris BioTechnologies Enables Personalized Precision Medicine and Wellness -- an Invited Presentation at the BIO 2014 International Convention
Marketwire - Wed Jun 25, 7:52AM CDT
Iris BioTechnologies Inc. (OTCQB: IRSB) is growing. This is the first news release since Iris's previous press release on April 18, 2014, announcing that Iris was a winner of the 2014 IAIR AWARDS, the Company was issued US patent 8,693,751, which enables and accelerates the practice of personalized precision medicine, and Iris was invited to present at the 2014 BIO International Convention, taking place June 23-26 in San Diego, California.